NEO: Another idea I had was that I haven't heard much from management about Cap ex for some time. As the genetics testing business is evolving quickly, they may be interested in the faster and more highly automated analysis machines that are coming onto the market. Gotta assume that faster is expensive, but may laos be less labor intensive.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.